Protect them from the dangers of glucose toxicity
Delays the progression of diabetes and provides additional cardiovascular benefits
The simple way to flatten the peaks
Glucobay® - A unique mechanism of action that controls glucose absorption and post-meal hyperglycaemia
Protection in the long-term
Glucobay® - An exceptional safety profile which avoids hypoglycaemia and weight gain
Protect them from the dangers of glucose toxicity
Glucobay® - An exceptional safety profile which avoids hypoglycaemia and weight gain
The simple way to flatten the peaks
Glucobay® - Delays the progression of diabetes and provides additional cardiovascular benefits
Protection in the long-term
Glucobay® - Effective long-term glucose control that may preserve beta-cell function
Protect them from the dangers of glucose toxicity
Glucobay® - A unique mechanism of action that controls glucose absorption and post-meal hyperglycaemia
The simple way to flatten the peaks
Glucobay® - Effective long-term glucose control that may preserve beta-cell function
Protection in the long-term
Glucobay® - Delays the progression of diabetes and provides additional cardiovascular benefits
Protect them from the dangers of glucose toxicity
Glucobay® - Effective long-term glucose control that may preserve beta-cell function
The simple way to flatten the peaks
Glucobay® - An exceptional safety profile which avoids hypoglycaemia and weight gain
Protection in the long-term
Glucobay® - A unique mechanism of action that controls glucose absorption and post-meal hyperglycaemia
International Availability
Glucobay® is approved in more than 95 countries. Visit our local websites and learn more about Glucobay® in your language.
What is Glucobay®?
We are providing you an overview about Glucobay® and its active substance Acarbose, the mode of action and indications for Acarbose.
Welcome to the Professional’s Area of Glucobay
If you are a patient, please enter the patient’s website:
About Glucobay®
Glucobay® – the most extensively investigated and widely prescribed α-glucosidase inhibitor – protects against glucose toxicity and post-meal hyperglycaemia by delaying the absorption of carbohydrate from the small intestine. It is an effective first-line drug therapy for patients with newly diagnosed type 2 diabetes, and induces a further improvement in glycemic control when used in combination with other anti-diabetic agents.
Glucobay® offers an effective long-term glucose control with an exceptional safety profile and is a convenient and potent option for the treatment of type 2 diabetes, with a potential added benefit of reducing cardiovascular risk (Hanefeld et al. Eur Heart J 2004) . An effective glycemic control and compliance are critical in patients with type 2 diabetes to prevent disease progression and to reduce the risk of cardiovascular and other complications.
In addition to information on Glucobay®, this website provides some material and services that may be helpful for you to improve patient education for a better compliance.